A pre-specified analysis of the DAPA-CKD trial

dapa totoDapagliflozin reduced the risk of kidney failure and prolonged survival in participants with chronic kidney disease with and without type 2 diabetes, includingDapa Toto Lari ; 󱚸. Worked at FC Barcelona ; 󱜧. Studied at UNJARA(UNIVERSITAS JALAN RAYA) ; 󱜧. Went to Universitas Nusa Cendana (Undana) Kupang, NTT ; 󱜏. Lives in